research and development
The company plans to recruit about 12,000 individuals, split between cancer cases and controls, to train and test a newly developed 22-cancer early detection test.
Sherlock Biosciences Foundation Grants License to Rokline Health for COVID-19 CRISPR Tests
Sherlock Biosciences said that under the agreement, Rokline Health will develop and manufacture high-throughput CRISPR kits in the US.
Seven Bridges, ZS Partner for Multiomics Analytics in Drug Development
The partners hope to provide scalable "one-stop" analytics convenience to ZS's pharmaceutical clients.
DARPA program managers said they are developing different testing modalities that are crucially linked in their objective to facilitate more comprehensive and faster testing.
Molzym said a new analytic platform, called AutoSepT, would enable fast pathogen identification directly from specimens in less than five hours.
Nov 23, 2020
Oct 14, 2020
Oct 8, 2020
Sep 22, 2020